Role of programmed cell death in the immunopathogenesis of sepsis

Drug Discovery Today: Disease Mechanisms

Volumn 4, Issue 4, 2007, Pages 223-230

  Perl, Mario ^a   Chung, Chun Shiang ^a   Swan, Ryan ^a   Ayala, Alfred ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENOMEDULLIN; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BIM PROTEIN; CASPASE 8; CASPASE INHIBITOR; COMPLEMENT COMPONENT C5A; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN BID; PROTEIN KINASE B; PROTEIN P53; PROTEINASE INHIBITOR; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADAPTIVE IMMUNITY; APOPTOSIS; DEATH; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; INFLAMMATION; INHIBITION KINETICS; INNATE IMMUNITY; INTESTINE; LIVER; LUNG; LYMPHOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PARENCHYMA; PHAGOCYTOSIS; REGULATORY MECHANISM; REVIEW; SEPSIS;

EID: 47249103385     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2008.02.010     Document Type: Review

References (66)

1. Angus D.C., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29 (2001) 1303-1310
2. Martin G.S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348 (2003) 1546-1554
3. Angus D.C., and Wax R.S. Epidemiology of sepsis: an update. Crit. Care Med. 29 (2001) S109-S116
4. Russell J.A. Management of sepsis. N. Engl. J. Med. 355 (2006) 1699-1713
5. Opal S.M., and Huber C.E. The role of interleukin-10 in critical illness. Curr. Opin. Infect. Dis. 13 (2000) 221-226
6. Leist M., and Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2 (2001) 589-598
7. Krammer P.H. CD95's deadly mission in the immune system. Nature 407 (2000) 789-795
8. Krammer P.H. The CD95(APO-1/Fas)/CD95L system. Toxicol. Lett. 102-103 (1998) 131-137
9. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
10. Korsmeyer S.J., et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Diff. 7 (2000) 1166-1173
11. Hockenbery D., et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348 (1990) 334-336
12. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39 (2003) 615-647
13. Szegezdi E., et al. Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann. N. Y. Acad. Sci. 1010 (2003) 186-194
14. Shiraishi H., et al. ER stress-induced apoptosis and caspase-12 activation occurs downstream of mitochondrial apoptosis involving Apaf-1. J. Cell Sci. 119 (2006) 3958-3966
15. Saleh M., et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 440 (2006) 1064-1068
16. Ayala A., et al. The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 3 (1995) 259-267
17. Wang S.-D., et al. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152 (1994) 5014-5021
18. Ayala A., et al. Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87 (1996) 4261-4275
19. Chung C.S., et al. Is Fas ligand or endotoxin responsible for mucosal lymphocyte apoptosis in sepsis?. Arch. Surg. 133 (1998) 1213-1220
20. Ayala A., et al. Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin. Immunology 97 (1999) 45-55
21. Ayala A., et al. Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91 (1998) 1362-1372
22. Ayala A., et al. Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis?. Shock 11 (1999) 211-217
23. Guo R.F., et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J. Clin. Invest 106 (2000) 1271-1280
24. Ayala A., et al. IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 14 (2001) 37-48
25. Hotchkiss R.S., et al. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162 (1999) 4148-4156
26. Chung C.S., et al. Deficiency of gammadelta T lymphocytes contributes to mortality and immunosuppression in sepsis. Am. J. Physiol Regul. Integr. Comp. Physiol. 291 (2006) R1338-R1343
27. Hotchkiss R.S., et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27 (1999) 1230-1251
28. Le T.Y., et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18 (2002) 487-494
29. Hotchkiss R.S., et al. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J. Immunol. 174 (2005) 5110-5118
30. Coopersmith C.M., et al. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. JAMA 287 (2002) 1716-1721
31. Hotchkiss R.S., et al. Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice. Crit. Care Med. 25 (1997) 1298-1307
32. Perl M., et al. Silencing of fas, but not caspase-8, in lung epithelial cells ameliorates pulmonary apoptosis, inflammation, and neutrophil influx after hemorrhagic shock and sepsis. Am. J. Pathol. 167 (2005) 1545-1559
33. Perl M., et al. Fas Induced Pulmonary Apoptosis and Inflammation During Indirect Acute Lung Injury. Am. J. Respir. Crit. Care Med. 176 (2007) 591-601
34. Kim Y.M., et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology 32 (2000) 770-778
35. Wesche-Soldato D.E., et al. CD8+ T cells promote inflammation and apoptosis in the liver after sepsis: role of Fas-FasL. Am. J. Pathol. 171 (2007) 87-96
36. Mutunga M., et al. Circulating endothelial cells in patients with septic shock. Am. J. Respir. Crit. Care Med. 163 (2001) 195-200
37. Gambim M.H., et al. Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction. Crit. Care 11 (2007) R107
38. Coopersmith C.M., et al. Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit. Care Med. 30 (2002) 195-201
39. Lauber K., et al. Clearance of apoptotic cells: getting rid of the corpses. Mol. Cell 14 (2004) 277-287
40. Fadok V.A., et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101 (1998) 890-898
41. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
42. Fadok V.A., et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
43. Albert M.L., et al. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188 (1998) 1359-1368
44. Swan R., et al. Polymicrobial sepsis enhances clearance of apoptotic immune cells by splenic macrophages. Surgery 142 (2007) 253-261
45. Hotchkiss R.S., et al. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. U.S.A 100 (2003) 6724-6729
46. Albert M.L., et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 (1998) 86-89
47. Schulz O., and Reis e Sousa. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107 (2002) 183-189
48. Taneja R., et al. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit. Care Med. 32 (2004) 1460-1469
49. Ayala A., et al. Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency. Am. J. Pathol. 161 (2002) 2283-2294
50. Perl M., et al. Beneficial Versus Detrimental Effects of Neutrophils Are Determined by the Nature of the Insult. J. Am. Coll. Surg. 204 (2007) 840-852
51. Iwata A., et al. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J. Immunol. 171 (2003) 3136-3141
52. Hotchkiss R.S., et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14541-14546
53. Hotchkiss R.S., et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1 (2000) 496-501
54. Chung C.S., et al. Inhibition of Fas signaling prevents hepatic injury and improves organ blood flow during sepsis. Surgery 130 (2001) 339-345
55. Chung C.S., et al. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukoc. Biol. 74 (2003) 344-351
56. Wesche-Soldato D.E., et al. In vivo delivery of Caspase 8 or Fas siRNA improves the survival of septic mice. Blood 106 (2005) 2295-2301
57. Schwulst S.J., et al. Agonistic monoclonal antibody against CD40 receptor decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 177 (2006) 557-565
58. Hotchkiss R.S., et al. TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo. J. Immunol. 176 (2006) 5471-5477
59. Chang K.C., et al. Multiple triggers of cell death in sepsis: death receptor and mitochondrial-mediated apoptosis. FASEB J. 21 (2007) 708-719
60. Schwulst, S.J. et al. Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis. Shock 29 (Epup ahead of press, 1/9/2008; PMID: 18197142)
61. Hotchkiss R.S., et al. p53-dependent and -independent pathways of apoptotic cell death in sepsis. J. Immunol. 164 (2000) 3675-3680
62. Zhou M., et al. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann. Surg. 240 (2004) 321-330
63. Weaver J.G., et al. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J. 18 (2004) 1185-1191
64. Bommhardt U., et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J. Immunol. 172 (2004) 7583-7591
65. Cobb J.P., et al. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery 126 (1999) 438-442
66. Chung C.S., et al. SOCS-1 is a central mediator of steroid-increased thymocyte apoptosis and decreased survival following sepsis. Apoptosis 12 (2007) 1143-1153